CellPoint Adds $11.2 Million

CellPoint Diagnostics Inc., a Richmond, Va.-based cancer diagnostics company, has raised $11.22 million in Series A-1 funding, according to a regulatory filing. Northgate Capital Group was joined by return backer Mohr, Davidow Ventures. The company had raised an $8.5 million Series A round late last year. www.cellpointdiagnostics.com